Navigation Links
Biogen Idec's oral compound BG-12 achieves development milestones in MS and RA
Date:12/7/2009

e MS combination therapy studies.

Additionally, as an oral compound, BG-12 holds promise for patients with RA. Its combination of anti-inflammatory and potential cytoprotective properties support the compound's evaluation in RA.

BG-12 is an oral formulation of dimethyl fumarate. Fumaderm, a therapeutic for the treatment of psoriasis in Germany, includes dimethyl fumarate as one of the active ingredients. Fumaderm has more than 14 years of post-marketing experience and approximately 100,000 patient years of use.


'/>"/>

Contact: Tracy Vineis
617-914-6524
GCI Health
Source:Eurekalert

Page: 1 2

Related biology news :

1. The cooperative view: New evidence suggests a symbiogenetic origin for the centrosome
2. New microsensor measures volatile organic compounds in water and air on-site
3. Naturally-occurring apple compounds reduce risk of pancreatic cancer
4. Chemical compound present in detergents produce bacteria alterations in agricultural soils
5. Synthetic compound promotes death of lung-cancer cells, tumors
6. Natural compound in broccoli could treat devastating genetic skin disorder
7. New form of compound stimulates research on hydrogen storage
8. Protein protects brain against compound in lead poisoning, liver disease
9. A compound extracted from olives inhibits cancer cells growth and prevents their appearance
10. UDs Bobev receives NSF Early Career Award for research on novel compounds of rare Earth metals
11. UF scientists discover compound that could lead to new blood pressure drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... exports from Washington, Oregon, northern California, and Alaska totaled ... quarter of 2014, an increase of more than 10 ... U.S. Forest Service,s Pacific Northwest Research Station reported today. ... by 4 percent to 247 million board feet. , ... more than 5 percent to $390 million in the ...
(Date:8/27/2014)... Wis. The mechanical force that a single fungal cell ... vanishingly small, but it plays a heavy role in setting ... In fact, it may not be too much of a ... land without the ability to respond to the touch of ... An, a professor of agronomy at the University of Wisconsin-Madison. ...
(Date:8/27/2014)... functional near infrared spectroscopy (fNIRS), Kessler Foundation researchers ... with multiple sclerosis (MS) and healthy controls. This ... activation was studied using fNIRS while participants performed ... using functional near infrared spectroscopy (fNIRS) in multiple ... Brain Imaging and Behavior . Authors are ...
Breaking Biology News(10 mins):West coast log exports up, lumber exports down in second quarter of 2014 2A touching story: The ancient conversation between plants, fungi and bacteria 2A touching story: The ancient conversation between plants, fungi and bacteria 3Kessler Foundation researchers publish first study of brain activation in MS using fNIRS 2
... a man with apparent battle wounds and curvature of the ... the University of Leicester. The University of Leicester has ... King Richard III with Leicester City Council, in association with ... third week, has yielded dramatic findings of human remains which ...
... Va., September 12, 2012 Using old deeds and ... a glimpse of the composition of the forests that ... changed the landscape., "European Settlement-Era Vegetation of the Monongahela ... scientist and her West Virginia University colleague answered questions ...
... This release is available in French . ... University of Montreal have identified several novel genes that ... way their immune system responds to malaria infection. This ... to specific immune responses to malaria and ultimately to ...
Cached Biology News:King Richard III search in new phase after 'discovery has potential to rewrite history' 2King Richard III search in new phase after 'discovery has potential to rewrite history' 3King Richard III search in new phase after 'discovery has potential to rewrite history' 4King Richard III search in new phase after 'discovery has potential to rewrite history' 5King Richard III search in new phase after 'discovery has potential to rewrite history' 6King Richard III search in new phase after 'discovery has potential to rewrite history' 7King Richard III search in new phase after 'discovery has potential to rewrite history' 8King Richard III search in new phase after 'discovery has potential to rewrite history' 9Old deeds, witness trees offer glimpse of pre-settlement forest in West Virginia 2Old deeds, witness trees offer glimpse of pre-settlement forest in West Virginia 3Genetic make-up of children explains how they fight malaria infection 2
(Date:8/27/2014)... 27, 2014  A novel biomarker for rheumatoid ... better identify early-stage disease, when treatment can often ... a new study in The Journal of Rheumatology. ... DGX ) and other institutions found that ... conventional antibody-serum testing, including rheumatoid factor (RF) and ...
(Date:8/27/2014)... Aug. 27, 2014 Guggenheim Securities, the investment ... announced the hiring of veteran equity analyst Charles "Tony" ... Mr. Butler will focus on the biotech/biopharma sector. ... wealth of experience and a broad network of relationships ... Managing Director and Head of Equities at Guggenheim Securities. ...
(Date:8/27/2014)... CO (PRWEB) August 27, 2014 Flagship ... analysis services to the pharmaceutical and medical device ... expansion. The fast growing company has consolidated its ... Aurora and Boulder to Westminster, CO, just north of ... Histology Lab, 7575 W. 103rd Ave., Suite 100, Westminster, ...
(Date:8/27/2014)... -- Research and Markets  has announced the addition ... Industry Report 2014" report to their offering. ... Industry Report 2014 is a professional and in-depth study ... mass spectrometer industry. The report provides a ... and industry chain structure. The isotope ratio mass spectrometer ...
Breaking Biology Technology:Novel Biomarker Detects Early Rheumatoid Arthritis Better than Conventional Methods Alone, According to Journal of Rheumatology Study 2Novel Biomarker Detects Early Rheumatoid Arthritis Better than Conventional Methods Alone, According to Journal of Rheumatology Study 3Novel Biomarker Detects Early Rheumatoid Arthritis Better than Conventional Methods Alone, According to Journal of Rheumatology Study 4Guggenheim Securities Hires Analyst Charles "Tony" Butler to Expand Healthcare Coverage 2Flagship Biosciences Announces Relocation and Expansion 2Global Stable Isotope Ratio Mass Spectrometer Industry Report 2014 2
... Repligen Corporation (Nasdaq: RGEN ) today reported results ... Total revenue for the quarter was $5,061,000 compared to total ... The prior year results were favorably impacted by a one-time ... U.S. sales of Orencia(R) prior to the April 2008 patent licensing ...
... , SEATTLE, Aug. 6 Cell Therapeutics, ... financial results for the second quarter and six months ended June ... 2009 was a transforming quarter for the Company as we reported, ... American Society of Clinical Oncology Annual Meeting and completed the submission ...
... To use hydrogen as a clean energy source, some engineers ... compressing the gas into a tank. A gas flows easily ... molecule requires a catalyst. Now, researchers reveal new details about ... catalysts for use in hydrogen energy applications such as fuel ...
Cached Biology Technology:Repligen Reports First Quarter Fiscal Year 2010 Financial Results 2Repligen Reports First Quarter Fiscal Year 2010 Financial Results 3Repligen Reports First Quarter Fiscal Year 2010 Financial Results 4Repligen Reports First Quarter Fiscal Year 2010 Financial Results 5Repligen Reports First Quarter Fiscal Year 2010 Financial Results 6Repligen Reports First Quarter Fiscal Year 2010 Financial Results 7Cell Therapeutics Second Quarter Net Loss Decreases 54%; Pixantrone NDA Submitted to the FDA for Approval 2Cell Therapeutics Second Quarter Net Loss Decreases 54%; Pixantrone NDA Submitted to the FDA for Approval 3Cell Therapeutics Second Quarter Net Loss Decreases 54%; Pixantrone NDA Submitted to the FDA for Approval 4Cell Therapeutics Second Quarter Net Loss Decreases 54%; Pixantrone NDA Submitted to the FDA for Approval 5Cell Therapeutics Second Quarter Net Loss Decreases 54%; Pixantrone NDA Submitted to the FDA for Approval 6Cell Therapeutics Second Quarter Net Loss Decreases 54%; Pixantrone NDA Submitted to the FDA for Approval 7New clues about a hydrogen fuel catalyst 2New clues about a hydrogen fuel catalyst 3
... c-Jun N-terminal kinase (JNK) is one of ... luciferase has been used as a sensitive ... Luciferase provides a 1000-fold increase in sensitivity ... (CAT) assay. Firefly luciferase catalyzes the oxidative ...
... number is a new product ... Cornings product number. If showing ... under the old Sigma-Aldrich number ... for assistance. ID clarifier: filling ...
... Linkage: This CLS number is ... to easily match Cornings product ... yet, please order under the ... contact customer service for assistance. ...
... DMEM and harvested at the log phase of ... in their native forms, cells were fixed in ... 12-well (5 mm) adhesive coated slide, with each ... and to minimize background staining. Each well ...
Biology Products: